News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

UCB Japan Co., Ltd. Announces Sales Channel Change Of Zyrtec Tablet In Japan


10/19/2005 5:13:08 PM

Tokyo (JCNN) - On April 18, UCB Japan announced its decisions on the domestic distribution of Zyrtec. Launched in Japan in September 1998, Zyrtec is an antiallergic agent used in over 100 countries worldwide. First, UCB Japan has agreed with its sales partner Sumitomo Pharmaceuticals to terminate the distribution agreement for Zyrtec, effective June 30.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES